HUP2300199A1 - Benzofuran-3-carboxylic acid amides and benzofuran-3-carbonylbenzamides, process for their preparation with high selectivity, and pharmaceutical compositions containing them - Google Patents
Benzofuran-3-carboxylic acid amides and benzofuran-3-carbonylbenzamides, process for their preparation with high selectivity, and pharmaceutical compositions containing themInfo
- Publication number
- HUP2300199A1 HUP2300199A1 HU2300199A HUP2300199A HUP2300199A1 HU P2300199 A1 HUP2300199 A1 HU P2300199A1 HU 2300199 A HU2300199 A HU 2300199A HU P2300199 A HUP2300199 A HU P2300199A HU P2300199 A1 HUP2300199 A1 HU P2300199A1
- Authority
- HU
- Hungary
- Prior art keywords
- benzofuran
- carbonylbenzamides
- preparation
- carboxylic acid
- pharmaceutical compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D307/80—Radicals substituted by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D307/83—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Plural Heterocyclic Compounds (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU2300199A HUP2300199A1 (en) | 2023-06-21 | 2023-06-21 | Benzofuran-3-carboxylic acid amides and benzofuran-3-carbonylbenzamides, process for their preparation with high selectivity, and pharmaceutical compositions containing them |
| PCT/HU2024/050044 WO2024261504A1 (en) | 2023-06-21 | 2024-06-20 | Benzofuran-3-carboxylic acid amides and benzofuran-3- carbonyl-benzamides, method for their production with high selectivity, and pharmaceutical compositions containing them |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU2300199A HUP2300199A1 (en) | 2023-06-21 | 2023-06-21 | Benzofuran-3-carboxylic acid amides and benzofuran-3-carbonylbenzamides, process for their preparation with high selectivity, and pharmaceutical compositions containing them |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUP2300199A1 true HUP2300199A1 (en) | 2024-12-28 |
Family
ID=93934984
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU2300199A HUP2300199A1 (en) | 2023-06-21 | 2023-06-21 | Benzofuran-3-carboxylic acid amides and benzofuran-3-carbonylbenzamides, process for their preparation with high selectivity, and pharmaceutical compositions containing them |
Country Status (2)
| Country | Link |
|---|---|
| HU (1) | HUP2300199A1 (en) |
| WO (1) | WO2024261504A1 (en) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006094235A1 (en) * | 2005-03-03 | 2006-09-08 | Sirtris Pharmaceuticals, Inc. | Fused heterocyclic compounds and their use as sirtuin modulators |
| PE20080403A1 (en) * | 2006-07-14 | 2008-04-25 | Amgen Inc | FUSED HETEROCYCLIC DERIVATIVES AND METHODS OF USE |
| US20130072473A1 (en) * | 2011-05-09 | 2013-03-21 | Proteostasis Therapeutics, Inc. | Compounds for treating protein folding disorders |
-
2023
- 2023-06-21 HU HU2300199A patent/HUP2300199A1/en unknown
-
2024
- 2024-06-20 WO PCT/HU2024/050044 patent/WO2024261504A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2024261504A1 (en) | 2024-12-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUE071190T2 (en) | Ternary single crystal positive electrode material, its preparation method and application | |
| FR3037956B1 (en) | NOVEL AMINO ACID DERIVATIVES, PROCESS FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | |
| HUE061758T2 (en) | New hydroxy acid derivatives, process for their production and pharmaceutical preparations containing them | |
| HUE049507T2 (en) | Novel piperidinyl derivatives, processes for their preparation and pharmaceutical compositions containing them | |
| BR112014028841A2 (en) | process for preparing n- [5- (3,5-difluoro-benzyl) -1h-indazol-3-yl] -4- (4-methyl-piperazin-1-yl) -2- (tetrahydro-pyran -4-ylamino) -benzamide | |
| MY159816A (en) | New co-crystals of agomelatine, a process for their preparation and pharmaceutical compositions containing them | |
| HRP20180113T1 (en) | USE OF METFORMIN IN COMBINATION WITH GLUCOCINASE ACTIVATOR AND COMPOSITIONS CONTAINING METFORMIN AND GLUCOCINASE ACTIVATOR | |
| EA201791537A1 (en) | PHARMACEUTICAL COMPOSITION ON THE BASIS OF NANOPARTICLES OF DOCETAXEL-ALBUMIN, METHOD FOR ITS PREPARATION AND ITS APPLICATION | |
| EP3946697C0 (en) | Creatine/creatine biosensors containing outer membrane compositions | |
| HUE067660T2 (en) | Chocolate products, ingredients, processes and applications | |
| CY1121660T1 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF HIV INFECTIONS | |
| PH12020500278A1 (en) | Pharmaceutical composition and method for preparing same | |
| MX393721B (en) | CHEWABLE GEL PRODUCTS FOR ACTIVE PHARMACEUTICAL INGREDIENTS. | |
| HUP2300199A1 (en) | Benzofuran-3-carboxylic acid amides and benzofuran-3-carbonylbenzamides, process for their preparation with high selectivity, and pharmaceutical compositions containing them | |
| BR112019000521A2 (en) | dapagliflozin intermediate crystal form and method of preparation thereof | |
| CY1117567T1 (en) | KITCHEN SULPHATE TYPE-SHARP AND METHOD FOR PREPARING IT | |
| MX2023003652A (en) | Crystalline form of tegavivint, method of preparation, and use thereof. | |
| BR112022009469A2 (en) | PROCESS FOR PREPARING A C5-C6 ALDARIC ACID AND/OR LACTONE (OR LACTONES) THEREOF | |
| HUP2400049A1 (en) | Process for the production of ammonium-manganese-iron-phosphate, lithium-manganese-iron-phosphate and its application | |
| WO2018060962A3 (en) | Metformin amino acid compounds and methods of using the same | |
| EP3814340C0 (en) | NOVEL CATEHOL DERIVATIVES OR THEIR SALTS, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| WO2017118822A3 (en) | "multi-target" compounds with inhibitory activity towards histone deacetylases and tubulin polymerisation, for use in the treatment of cancer | |
| UA112407C2 (en) | AGOMELATIN CO-CRYSTALS, THE METHOD OF THEIR MANUFACTURING, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| WO2018035509A3 (en) | Small molecules having antiviral properties | |
| EP4324835A4 (en) | PYRIMIDINONE DERIVATIVE AND ITS PREPARATION PROCESS, PHARMACEUTICAL COMPOSITION AND USE |